ANRO Alto Neuroscience, Inc.
Healthcare$21.22-1.49%ClosedMarket Cap: $744.7M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$30.75
Target (Median)
$31.50
Target Range
$24.00 - $36.00
Upside from current price: 44.9%
Rating Distribution
0 Strong Buy11 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-18 | Baird | maintain | Outperform | Outperform |
| 2026-05-14 | Wedbush | maintain | Neutral | Neutral |
| 2026-05-11 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-04-22 | Chardan Capital | maintain | Buy | Buy |
| 2026-04-02 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-04-02 | Jones Trading | maintain | Buy | Buy |
| 2026-04-02 | Baird | maintain | Outperform | Outperform |
| 2026-04-02 | Wedbush | maintain | Neutral | Neutral |
| 2026-03-17 | Chardan Capital | maintain | Buy | Buy |
| 2026-02-17 | BTIG | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-3.15 | $0.00 | 8 |
| Sun Dec 31 | $-3.18 | $6.2M | 7 |
| Mon Dec 31 | $-2.78 | $55.6M | 2 |
| Tue Dec 31 | $-1.02 | $211.5M | 5 |